<DOC>
	<DOCNO>NCT00660166</DOCNO>
	<brief_summary>The purpose research study examine safety infusing escalated dos allogeneic ( relative patient ) , enrich natural killer ( NK ) cell autologous ( patient ) stem cell transplantation . The hypothesis infusion NK cell early autologous stem cell transplant help eliminate eradicate residual cancerous cell remain body may survive chemotherapy radiation .</brief_summary>
	<brief_title>Human Leukocyte Antigen ( HLA ) Class I Haplotype Mismatched Natural Killer Cell Infusions</brief_title>
	<detailed_description>Natural killer cell blood cell responsible eliminate cancer cell especially . It show NK cell come `` mismatch '' person ( relative ) good chance patient 's NK cell recognize kill cancer cell . These cell collect blood parent , child sibling preparation laboratory , give patient early autologous stem cell transplantation like blood platelet transfusion . A person diagnose blood tumor receive autologous stem cell transplant chance his/her cancer come back . This study use NK cell obtain relative prevent disease recurrence potentially eliminate eradicate residual cancerous cell .</detailed_description>
	<criteria>Patients undergo autologous stem cell transplant follow disease : Acute Myeloid Leukemia NonHodgkin 's Lymphoma Hodgkin 's Disease Multiple Myeloma Age 13 70 year old Able give inform consent Hepatic renal function : bilirubin le equal 2x normal limit , AST ALT less equal 2x normal limit , serum creatinine less equal 1.5x normal ECOG Performance Status less equal 1 ( plan time transplantation ) Patients active infection Patients recover sufficiently side effect autologous transplant ( i.e . &gt; grade 2 toxicity organ system ) Patients insufficient engraftment parameter accord follow criterion : WBC &lt; 2,500 /mm3 platelet &lt; 50,000/mm3 Radiation therapy , chemotherapy , immunotherapy begin one week NKcell infusion last 2 week NKcell infusion . Intrinsic impaired organ function ( state ) . Physical psychiatric condition estimation PI designee place patient highrisk toxicity noncompliance . Uncontrolled , lifethreatening infection time infusion . Concurrent treatment corticosteroid and/or immunosuppressive drug .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Natural killer cell</keyword>
	<keyword>autologous stem cell transplant</keyword>
	<keyword>immunotherapy</keyword>
</DOC>